Bellicum Pharmaceuticals financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.78M | $0.28M | $0.39M | $0.19M | $1.12M | $7.14M | $0.50M | $6.20M | $1.50M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -280.29% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-71.00 | $-18.40 | $-25.70 | $-28.38 | $-24.40 | $-24.01 | $-0.81 | $0.00 | |||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
2.72m | 2.69m | 2.71m | 3.32m | 4.34m | 4.99m | 5.06m | 8.4m | 8.61m | 11.83m | 0m |
| OCF | Operating Cash Flow |
|
$-57.31M | $-35.73M | $-50.44M | $-72.98M | $-74.78M | $-77.57M | $-56.65M | $-23.11M | $-25.78M | $0.00M | $0.00M |
| FCF | Free Cash Flow |
|
$-58.11M | $-41.15M | $-57.66M | $-85.12M | $-76.40M | $-78.09M | $-57.28M | $-23.12M | $-25.80M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-232.24 | $-15.62 | $-21.39 | $-26.84 | $-18.99 | $-16.67 | $-9.94 | $-2.01 | $-0.84 | $0.00 | $0.00 |